Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population
- PMID: 28886145
- PMCID: PMC5590973
- DOI: 10.1371/journal.pone.0184563
Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population
Abstract
The determinants of immunological protection against Mycobacterium tuberculosis (M.tb) infection in humans are not known. Mycobacterial growth inhibition assays have potential utility as in vitro surrogates of in vivo immunological control of M.tb. We evaluated a whole blood growth inhibition assay in a setting with high burden of TB and aimed to identify immune responses that correlate with control of mycobacterial growth. We hypothesized that individuals with underlying M.tb infection will exhibit greater M.tb growth inhibition than uninfected individuals and that children aged 4 to 12 years, an age during which TB incidence is curiously low, will also exhibit greater M.tb growth inhibition than adolescents or adults. Neither M.tb infection status, age of the study participants, nor M.tb strain was associated with differential control of mycobacterial growth. Abundance and function of innate or T cell responses were also not associated with mycobacterial growth. Our data suggest that this assay does not provide a useful measure of age-associated differential host control of M.tb infection in a high TB burden setting. We propose that universally high levels of mycobacterial sensitization (through environmental non-tuberculous mycobacteria and/or universal BCG vaccination) in persons from high TB burden settings may impart broad inhibition of mycobacterial growth, irrespective of M.tb infection status. This sensitization may mask the augmentative effects of mycobacterial sensitization on M.tb growth inhibition that is typical in low burden settings.
Conflict of interest statement
Figures






Similar articles
-
Protection against mycobacterial infection: A case-control study of mycobacterial immune responses in pairs of Gambian children with discordant infection status despite matched TB exposure.EBioMedicine. 2020 Sep;59:102891. doi: 10.1016/j.ebiom.2020.102891. Epub 2020 Jul 13. EBioMedicine. 2020. PMID: 32675024 Free PMC article.
-
Mycobacterial Lipoprotein Z Triggers Efficient Innate and Adaptive Immunity for Protection Against Mycobacterium tuberculosis Infection.Front Immunol. 2019 Jan 16;9:3190. doi: 10.3389/fimmu.2018.03190. eCollection 2018. Front Immunol. 2019. PMID: 30700988 Free PMC article.
-
[Frontier of mycobacterium research--host vs. mycobacterium].Kekkaku. 2005 Sep;80(9):613-29. Kekkaku. 2005. PMID: 16245793 Japanese.
-
[Evolution of IGRA researches].Kekkaku. 2008 Sep;83(9):641-52. Kekkaku. 2008. PMID: 18979999 Review. Japanese.
-
In vitro cellular and cytokine responses to mycobacterial antigens: application to diagnosis of tuberculosis infection and assessment of response to mycobacterial vaccines.Am J Med Sci. 1997 Jun;313(6):364-71. doi: 10.1097/00000441-199706000-00009. Am J Med Sci. 1997. PMID: 9186152 Review.
Cited by
-
Whole Blood Mycobacterial Growth Assays for Assessing Human Tuberculosis Susceptibility: A Systematic Review and Meta-Analysis.Front Immunol. 2021 May 11;12:641082. doi: 10.3389/fimmu.2021.641082. eCollection 2021. Front Immunol. 2021. PMID: 34046032 Free PMC article.
-
Development and application of the direct mycobacterial growth inhibition assay: a systematic review.Front Immunol. 2024 Feb 6;15:1355983. doi: 10.3389/fimmu.2024.1355983. eCollection 2024. Front Immunol. 2024. PMID: 38380319 Free PMC article.
-
Friends and foes of tuberculosis: modulation of protective immunity.J Intern Med. 2018 May 27:10.1111/joim.12778. doi: 10.1111/joim.12778. Online ahead of print. J Intern Med. 2018. PMID: 29804292 Free PMC article.
-
Inflammatory Determinants of Differential Tuberculosis Risk in Pre-Adolescent Children and Young Adults.Front Immunol. 2021 Feb 25;12:639965. doi: 10.3389/fimmu.2021.639965. eCollection 2021. Front Immunol. 2021. PMID: 33717192 Free PMC article.
-
Protection against mycobacterial infection: A case-control study of mycobacterial immune responses in pairs of Gambian children with discordant infection status despite matched TB exposure.EBioMedicine. 2020 Sep;59:102891. doi: 10.1016/j.ebiom.2020.102891. Epub 2020 Jul 13. EBioMedicine. 2020. PMID: 32675024 Free PMC article.
References
-
- World Health Organization (WHO). WHO | Global tuberculosis report 2016 [Internet]. WHO. 2016. http://www.who.int/tb/publications/global_report/en/
-
- Lawn SD, Zumla AI. Tuberculosis. Lancet [Internet]. 2011;378(9785):57–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21420161 doi: 10.1016/S0140-6736(10)62173-3 - DOI - PubMed
-
- Blaser N, Zahnd C, Hermans S, Salazar-Vizcaya L, Estill J, Morrow C, et al. Tuberculosis in Cape Town: An age-structured transmission model. Epidemics. 2016;14:54–61. doi: 10.1016/j.epidem.2015.10.001 - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical